CRIS - Cannabinoid Research Initiative of Saskatchewan


An interdisciplinary research team that aims to obtain scientific evidence about the application of cannabinoids and cannabis derivatives
to humans and animals, for health, disease and disorders.

The team is based in Saskatoon Saskatchewan Canada at the University of Saskatchewan.

CRIS Activities &  News:

Mar 19-20, 2018: Indigenous inclusion in the hemp and cannabis industries: “Creating Sustainable Opportunities & Partnerships" Conference in Saskatoon with Dr. R. Laprairie & staff.

Mar 8, 2018: Cafe Scientifique: Cannabinoids: Molecules, Epidemiology and Public Policy. Johnson Shoyama Centre for the Study of Science and Innovation Policy & CRIS. Univ. Sask. 

Jan 21, 2018: Poster Presentation: Vuong S et al.  Development of a LC-MS/MS assay for bioactive cannabinoids in plasma of pediatric patients on cannabis oil therapy. Applications to the Clinical Lab (MSACL) 2018 US 10th Annual Conference, Palm Springs, California. January 21-25, 2018.

Jan 18, 2018: Publication: The future of type 1 cannabinoid receptor allosteric ligands

Dec 19, 2017: SHRF funding approved for an "Inaugural Saskatchewan Cannabinoid Research Symposium" Dr. R. Laprairie et al in 2018.  Stay tuned for details.

Dec 8, 2017: The Science of Medical Marijuana - On Campus News 25(6) p4

Dec 7, 2017: CRIS Poster at 2017 Sante Awards evening: CARE-E to CRIS. How a pilot study led to the development of a provincial research program.

Dec 1, 2017:  Huntsman, Tang-Wai, Alcorn, Lyon, Mousseau, Seifert, Prosser-Loose, Newmeyer. CARE-E Study: CBD in Children with Refractory Epilepsy.  Epilepsy Professional Magazine Autumn 2017. 

Dec 1, 2017: Cafe Scientifique (workshop slides)